News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gibbs Craig S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| Gibbs Craig S (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 7,900 options
@ $3.6, valued at
$28.4k
|
|
| 04/07/2020 |
4
| Gibbs Craig S (Chief Business Officer) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Gifted 9,124 shares
@ $0
Disposed/sold 9,124 shares
@ $0
Disposed/sold 47,327 shares
@ $0
Disposed/sold 47,327 shares
@ $0
Disposed/sold 5,924 shares
@ $0
Disposed/sold 112,903 options to buy
@ $2.015, valued at
$227.5k
Disposed/sold 64,515 options to buy
@ $5.27, valued at
$340k
Disposed/sold 72,902 options to buy
@ $8.7575, valued at
$638.4k
Disposed/sold 60,235 options to buy
@ $35.75, valued at
$2.2M
|
|
| 12/17/2019 |
4
| Gibbs Craig S (Chief Business Officer) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Granted 60,235 options to buy
@ $35.75, valued at
$2.2M
|
|
| 09/25/2019 |
4
| Gibbs Craig S (Chief Business Officer) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Gifted 9,124 shares
@ $0
Gifted 9,124 shares
@ $0
Gifted 9,124 shares
@ $0 |
|
| 08/29/2019 |
3/A
| Gibbs Craig S (Director) has filed a Form 3/A on Aridis Pharmaceuticals, Inc. |
| 08/14/2019 |
4
| Gibbs Craig S (Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options
@ $8.39, valued at
$293.7k
|
|
| 08/13/2018 |
3
| Gibbs Craig S (Director) has filed a Form 3 on Aridis Pharmaceuticals, Inc. |
| 06/27/2018 |
3
| Gibbs Craig S (Chief Business Officer) has filed a Form 3 on Forty Seven, Inc. |
|
|